Avanir Pharmaceuticals Inc
A California biopharmaceutical company built around a pioneering medicine for the brain and nerves. Its flagship product, NUEDEXTA, treats pseudobulbar affect, a neurological condition in which people suddenly break into uncontrollable laughing or crying fits, often after a stroke, ALS, or multiple sclerosis. The company began in 1988 as Lidak Pharmaceuticals, renamed itself Avanir in 1998, and was later acquired by Japan's Otsuka Pharmaceutical.
No tracked superinvestors held this security in this period.